Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rianne A. Weersink, David M. Burger, Kelly L. Hayward, Katja Taxis, Joost P.H. Drenth & Sander D. Borgsteede. (2020) Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations. Expert Opinion on Drug Metabolism & Toxicology 16:1, pages 45-57.
Read now
Read now
Articles from other publishers (43)
Syed Hassan Bin Usman Shah, Heather Valerio, Behzad Hajarizadeh, Gail Matthews, Maryam Alavi & Gregory J. Dore. (2023) Cascade of care among people with hepatitis B in New South Wales, Australia. Journal of Viral Hepatitis 30:12, pages 926-938.
Crossref
Crossref
Nerissa Hoi Ching Lee, Steven J Kiddle, Shardul Chandankhede, Shubh Agrawal, Daniel M Bean, Phillip R Hunt, Victoria E R Parker, Peter J Greasley & Philip Ambery. (2023) Evaluating clinical outcomes and prognosis in patients with cirrhosis and portal hypertension: a retrospective observational cohort study. BMJ Open Gastroenterology 10:1, pages e001234.
Crossref
Crossref
Salfarina Ezrina Mohmad Saberi & Lee Suan Chua. (2023) Potential of rosmarinic acid from Orthosiphon aristatus extract for inflammatory induced diseases and its mechanisms of action. Life Sciences 333, pages 122170.
Crossref
Crossref
Haoyu Wang & Fuquan Liu. (2023) Clinical characteristics of hepatopulmonary syndrome and hepatorenal syndrome and associated therapeutic potential of transjugular intrahepatic portosystemic shunt. iLIVER 2:1, pages 67-72.
Crossref
Crossref
Mo-Jong Kim, Jung-Hee Kim, Jang-Han Jung, Sung-Eun Kim, Hyoung-Su Kim, Myoung-Kuk Jang, Sang-Hoon Park, Myung-Seok Lee, Ki Tae Suk, Dong Joon Kim, Eun-Kyoung Choi & Ji-Won Park. (2023) Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy. Diagnostics 13:3, pages 333.
Crossref
Crossref
Sydnée L’Écuyer, Emmanuel Charbonney, François Martin Carrier & Christopher F. Rose. (2023) Implication of Hypotension in the Pathogenesis of Cognitive Impairment and Brain Injury in Chronic Liver Disease. Neurochemical Research.
Crossref
Crossref
Yin Liu, Lan-Wei Guo, Hui-Fang Xu, Rui-Hua Kang, Li-Yang Zheng, Lu-Yao Zhang, Qiong Chen, Xi-Bin Sun, You-Lin Qiao & Shao-Kai Zhang. (2022) Development and Validation of a Noninvasive Risk Score Model for Liver Cirrhosis in At-Risk Alcohol Drinkers Without HBV/HCV Infection. Cancer Prevention Research 15:11, pages 767-776.
Crossref
Crossref
Syed Hassan Bin Usman Shah, Maryam Alavi, Behzad Hajarizadeh, Gail V. Matthews, Marianne Martinello, Mark Danta, Janaki Amin, Matthew G. Law, Jacob George, Heather Valerio & Gregory J. Dore. (2022) Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales. JHEP Reports 4:10, pages 100552.
Crossref
Crossref
Agata Twardowska, Adam Makaro, Agata Binienda, Jakub Fichna & Maciej Salaga. (2022) Preventing Bacterial Translocation in Patients with Leaky Gut Syndrome: Nutrition and Pharmacological Treatment Options. International Journal of Molecular Sciences 23:6, pages 3204.
Crossref
Crossref
Tanner S. Slead, Christine L. Gremillion, Eli B. Cohen & M. Katherine Tolbert. (2022) Esophageal varices in dogs: A retrospective case series. Journal of Veterinary Internal Medicine 36:2, pages 493-499.
Crossref
Crossref
Jorge Fernando Miño Bernal, Edna López Morales, Nelly Jazmín Sandino & Daniel Molano Franco. (2022) Cirrosis hepática o falla hepática crónica agudizada: definición y clasificación. Revista Repertorio de Medicina y Cirugía 31:2, pages 112-122.
Crossref
Crossref
Xiaoyu Xie, Huanran Lv, Chenxi Liu, Xiaonan Su, Zhen Yu, Shouyang Song, Hongjun Bian, Miaomiao Tian, Chengyong Qin, Jianni Qi & Qiang Zhu. (2021) HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis. BMC Medicine 19:1.
Crossref
Crossref
Md Abdul Mumit Sarkar, Madhusudan Saha, Mohammad Naymul Hasan, Birendra Nath Saha & Avijit Das. (2021) Current status of knowledge, attitudes, and practices of barbers regarding transmission and prevention of hepatitis B and C virus in the north-west part of Bangladesh: A cross-sectional study in 2020. Public Health in Practice 2, pages 100124.
Crossref
Crossref
A. I. Bozhkov, A. A. Bozhkov, I. E. Ponomarenko, N. I. Kurguzova, R. A. Akzhyhitov, A. V. Goltvyanskii, E. M. Klimova & S. O. Shapovalov. (2021) Elimination of the toxic effect of copper sulfate is accompanied by the normalization of liver function in fibrosis. Regulatory Mechanisms in Biosystems 12:4, pages 655-663.
Crossref
Crossref
Nahoko Kikuchi, Haruki Uojima, Hisashi Hidaka, Shuichiro Iwasaki, Naohisa Wada, Kousuke Kubota, Takahide Nakazawa, Akitaka Shibuya, Tomoaki Fujikawa, Makoto Kako, Teruko Sato & Wasaburo Koizumi. (2021) Prospective study for an independent predictor of prognosis in liver cirrhosis based on the new sarcopenia criteria produced by the Japan Society of Hepatology. Hepatology Research 51:9, pages 968-978.
Crossref
Crossref
Max Shen, Anna Lee, Jay H. Lefkowitch & Howard J. Worman. (2021) Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center. Journal of Clinical and Translational Hepatology 000:000, pages 000-000.
Crossref
Crossref
Haya Omeish, Nada Hajjaj, Mohammad Abdulelah & Husam Bader. (2021) You Only Find What You Are Looking for: Concurrent Alcoholic Liver Cirrhosis and Undiagnosed Wilson’s Disease. Cureus.
Crossref
Crossref
J. M. Bolarín, M. D. Pérez-Cárceles, J. P. Hernández del Rincón, A. Luna, A. Minguela, M. Muro & I. Legaz. (2021) Causes of Death and Survival in Alcoholic Cirrhosis Patients Undergoing Liver Transplantation: Influence of the Patient’s Clinical Variables and Transplant Outcome Complications. Diagnostics 11:6, pages 968.
Crossref
Crossref
Tzu-Hao Li, Chih-Wei Liu, Chia-Chang Huang, Yu-Lien Tsai, Shiang-Fen Huang, Ying-Ying Yang, Chang-Youh Tsai, Ming-Chih Hou & Han-Chieh Lin. (2021) Non-Selective Beta-Blockers Decrease Infection, Acute Kidney Injury Episodes, and Ameliorate Sarcopenic Changes in Patients with Cirrhosis: A Propensity-Score Matching Tertiary-Center Cohort Study. Journal of Clinical Medicine 10:11, pages 2244.
Crossref
Crossref
Joanna Bacharewicz-Szczerbicka, Teresa Reduta, Anna Pawłoś & Iwona Flisiak. (2021) Paraphenylenediamine and related chemicals as allergens responsible for allergic contact dermatitis. Archives of Medical Science 17:3, pages 714-723.
Crossref
Crossref
Patrice Emery Itoudi Bignoumba, Tracy Alilangori, Arthur Mackossot, Ines Flore Maganga Moussavou, Arnaud Georgio Eyi Nguema, Monique Mbounja, Patrick Nzouto, Maryam Saibou & Jean Baptiste Moussavou Kombila. (2021) The cost of clinical treatment for decompensated cirrhosis at the university hospital center of Libreville. Gastroenterology & Hepatology: Open Access 11:2, pages 65-67.
Crossref
Crossref
Ricardo U Macías-Rodríguez, Astrid Ruiz-Margáin, Berenice M Román-Calleja, May E Espin-Nasser, Nayelli C Flores-García, Aldo Torre, Gretel Galicia-Hernández, Silvia L Rios-Torres, Gabriela Fernández-del-Rivero, Arturo Orea-Tejeda & Oscar A Lozano-Cruz. (2020) Effect of non-alcoholic beer, diet and exercise on endothelial function, nutrition and quality of life in patients with cirrhosis. World Journal of Hepatology 12:12, pages 1299-1313.
Crossref
Crossref
Furong Wu, Lijuan Ning, Ran Zhou & Aizong Shen. (2020) Screening and evaluation of key genes in contributing to pathogenesis of hepatic fibrosis based on microarray data. European Journal of Medical Research 25:1.
Crossref
Crossref
Hosim Soh, Jaeyoung Chun, Seung Wook Hong, Seona Park, Yun Bin Lee, Hyun Jung Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jong Pil Im, Yoon Jun Kim, Joo Sung Kim & Jung-Hwan Yoon. (2020) Child-Pugh B or C Cirrhosis Increases the Risk for Bleeding Following Colonoscopic Polypectomy. Gut and Liver 14:6, pages 755-764.
Crossref
Crossref
T. Bentsa. (2020) Liver Cirrhosis: Modern Approach to the Problem. Lviv clinical bulletin 3:31, pages 53-61.
Crossref
Crossref
Dhouha Grissa, Ditlev Nytoft Rasmussen, Aleksander Krag, Søren Brunak & Lars Juhl Jensen. (2020) Alcoholic liver disease: A registry view on comorbidities and disease prediction. PLOS Computational Biology 16:9, pages e1008244.
Crossref
Crossref
Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Alex Thompson, Jidong Jia, Jinlin Hou, Cosmas Rinaldi Adithya Lesmana, Adityo Susilo, Yasuhito Tanaka, Wah-Kheong Chan, Ed Gane, Arlinking K Ong-Go, Seng-Gee Lim, Sang Hoon Ahn, Ming-Lung Yu, Teerha Piratvisuth & Henry Lik-Yuen Chan. (2020) Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. The Lancet Gastroenterology & Hepatology 5:8, pages 776-787.
Crossref
Crossref
Maitreyi Raman, Puneeta Tandon & Manuela Merli. (2020) Nutrition in Liver Cirrhosis and Transplantation—Current State and Knowledge Gaps. Nutrients 12:3, pages 680.
Crossref
Crossref
Enrique Cervantes-Pérez, Gabino Cervantes-Guevara, Lorena A Cervantes-Pérez, Gabino Cervantes-Pérez, Guillermo Alonso Cervantes-Cardona, Sol Ramírez-Ochoa, Martha C Martínez-Soto Holguín, Alejandro González-Ojeda, Clotilde Fuentes-Orozco, Ricardo Sosa-Pérez, Josué Isaías Ruiz-Gallardo, Astrid Villaseñor-Ochoa, Miguel Robledo-Valdez & Fernanda I Ramírez-Casale. (2020) Estado actual del manejo nutricional en pacientes con trasplante hepático. Revista Mexicana de Trasplantes 9:2, pages 74-81.
Crossref
Crossref
Mustafa Z. Mahmoud, Abdalgadir Yonis, Alsafi Abdullah, Muna Ali, Ahmed Abukonna, Mohammed Alsaadi, Abdelmoneim Sulieman, Omer Hamid & Mahasin G. Hassan. (2020) Characterization of portal hypertension in hepatosplenic schistosoma mansoni patients using B-mode ultrasound. Journal of Radiation Research and Applied Sciences 13:1, pages 71-78.
Crossref
Crossref
J Qiao. (2019) Occurrence, diagnosis and management of hepatic fibrosis and cirrhosis: An updated literature review. Archives of Hepatitis Research 5:1, pages 022-026.
Crossref
Crossref
Yingying Li, Hongyu Li, Qiang Zhu, Emmanuel Tsochatzis, Ran Wang, Xiaozhong Guo & Xingshun Qi. (2019) Effect of acute upper gastrointestinal bleeding manifestations at admission on the in-hospital outcomes of liver cirrhosis: hematemesis versus melena without hematemesis. European Journal of Gastroenterology & Hepatology 31:11, pages 1334-1341.
Crossref
Crossref
Manjiang Li, Zusen Wang, Jingyu Cao, Bing Han, Hao Zou, Yunjin Zang & Liqun Wu. (2019) Risk factors and prognosis of patients with recurrent hepatocellular carcinoma who undergo liver re-resections. European Journal of Surgical Oncology 45:9, pages 1684-1690.
Crossref
Crossref
Grace Lai‐Hung Wong, Lilian Yan Liang, Raymond Kwok, Aric Josun Hui, Yee‐Kit Tse, Henry Lik‐Yuen Chan & Vincent Wai‐Sun Wong. (2019) Low Risk of Variceal Bleeding in Patients With Cirrhosis After Variceal Screening Stratified by Liver/Spleen Stiffness. Hepatology 70:3, pages 971-981.
Crossref
Crossref
Nisma Lena Bahaji Azami & Mingyu Sun. (2019) Zeaxanthin Dipalmitate in the Treatment of Liver Disease. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-14.
Crossref
Crossref
Anna Licata, Maria Giovanna Minissale, Filippo A. Montalto & Maurizio Soresi. (2019) Is vitamin D deficiency predictor of complications development in patients with HCV-related cirrhosis?. Internal and Emergency Medicine 14:5, pages 735-737.
Crossref
Crossref
Kai G. Kahl, Gabriel Eckermann, Helge Frieling & Thomas Hillemacher. (2019) Psychopharmacology in transplantation medicine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 88, pages 74-85.
Crossref
Crossref
Ming-Fang Wang, You-Bing Li, Xiao-Juan Gao, Hao-Yang Zhang, Su Lin & Yue-Yong Zhu. (2018) Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study. World Journal of Stem Cells 10:10, pages 138-145.
Crossref
Crossref
Hui-Chuan Huang, Ming-Yao Chen, Li-Wen Hsieh, Hsiao-Yean Chiu, Nae-Fang Miao, Chia-Shin Wu & Kuan-Chia Lin. (2018) Validation of a Symptoms Distress Scale in a Cirrhotic Population Using Item Response Theory. Nursing Research 67:5, pages 359-368.
Crossref
Crossref
Grace L. H. Wong, Raymond Kwok, Aric J. Hui, Yee-Kit Tse, Kai-Tin Ho, Angeline O. S. Lo, Kelvin L. Y. Lam, Heyson C. H. Chan, Rashid A. Lui, Kenneth H. D. Au, Henry L. Y. Chan & Vincent W. S. Wong. (2018) A new screening strategy for varices by liver and spleen stiffness measurement (LSSM) in cirrhotic patients: A randomized trial. Liver International 38:4, pages 636-644.
Crossref
Crossref
Pin-Chao Wang, Tao-Yang Wei, Tai-Chung Tseng, Hans Hsienhong Lin & Chia-Chi Wang. (2017) Cirrhosis has no impact on therapeutic responses of entecavir for chronic hepatitis B. European Journal of Gastroenterology & Hepatology 29:8, pages 946-950.
Crossref
Crossref
Mehmet Sayiner, Munkhzul Otgonsuren, Rebecca Cable, Issah Younossi, Mariam Afendy, Pegah Golabi, Linda Henry & Zobair M. Younossi. (2017) Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis. Journal of Clinical Gastroenterology 51:3, pages 254-260.
Crossref
Crossref
Yin Liu, Lan-wei Guo, Hui-fang Xu, Rui-hua Kang, Li-yang Zheng, Lu-yao Zhang, Qiong Chen, Xi-bin Sun, Shao-kai Zhang & You-Lin Qiao. (2021) Risk of Liver Cirrhosis in At-Risk Alcohol Drinkers Without HBV/HCV Infection: Development and Validation of a Simple Non-Invasive Risk Score Model. SSRN Electronic Journal.
Crossref
Crossref